0001593968-24-000862.txt : 20240614 0001593968-24-000862.hdr.sgml : 20240614 20240614160737 ACCESSION NUMBER: 0001593968-24-000862 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240612 FILED AS OF DATE: 20240614 DATE AS OF CHANGE: 20240614 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: King Rachel K. CENTRAL INDEX KEY: 0001589712 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26770 FILM NUMBER: 241044779 MAIL ADDRESS: STREET 1: C/O GLYCOMIMETICS, INC. STREET 2: 401 PROFESSIONAL DRIVE, SUITE 250 CITY: GAITHERSBURG STATE: MD ZIP: 20879 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NOVAVAX INC CENTRAL INDEX KEY: 0001000694 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 222816046 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 700 QUINCE ORCHARD ROAD CITY: GAITHERSBURG STATE: MD ZIP: 20878 BUSINESS PHONE: 240-268-2000 MAIL ADDRESS: STREET 1: 700 QUINCE ORCHARD ROAD CITY: GAITHERSBURG STATE: MD ZIP: 20878 4 1 primary_01.xml PRIMARY DOCUMENT X0508 4 2024-06-12 0001000694 NOVAVAX INC NVAX 0001589712 King Rachel K. 700 QUINCE ORCHARD ROAD GAITHERSBURG MD 20878 true false Common Stock 2024-06-12 4 M false 6670 0 A 18920 D Restricted Stock Units 0 2024-06-12 4 M false 6670 0 D 2024-06-12 2033-06-12 Common Stock 6670 0 D Stock Option (Right to Buy) 15.86 2024-06-12 4 A false 15630 15.86 A 2025-06-12 2034-06-12 Common Stock 15630 15630 D Restricted Stock Units 0 2024-06-12 4 A false 10420 0 A 2025-06-12 2034-06-12 Common Stock 10420 10420 D /s/Mark J. Casey, Attorney-in-Fact 2024-06-14